The challenge of progressive hepatitis C following liver transplantation.
Davis
Gary L
GL
D016572:Cyclosporine / Q000494:pharmacology*; D018450:Disease Progression; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival; D016174:Hepacivirus / Q000187:drug effects* / Q000302:isolation & purification; D019698:Hepatitis C, Chronic / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D017093:Liver Failure / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects* / Q000379:methods; D011183:Postoperative Complications / Q000517:prevention & control; D012008:Recurrence; D012680:Sensitivity and Specificity
D007166:Immunosuppressive Agents; D016572:Cyclosporine